Ratings Arq, Inc.

Equities

ARQ

US00770C1018

Real-time Estimate Cboe BZX 10:54:04 09/05/2024 pm IST 5-day change 1st Jan Change
7.595 USD -5.30% Intraday chart for Arq, Inc. +2.43% 0.00%

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 55% by 2026.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • The company does not generate enough profits, which is an alarming weak point.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Commodity Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
0.00% 268M
C
+6.15% 105B
A-
-4.19% 65.16B
A-
+51.90% 42.93B
B
+17.59% 39.48B
B
+7.28% 33.27B
A-
+12.02% 19.92B
B-
+16.25% 17.49B
C+
+20.35% 15.43B
B-
+9.86% 15.09B
B
Investor Rating
Trading Rating
-
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW